We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Outlines Regulatory Goals in Preparation for Leaving the EU
MHRA Outlines Regulatory Goals in Preparation for Leaving the EU
The U.K.’s Medicines and Healthcare products Regulatory Agency laid out its top 10 priorities for 2017 and 2018 — including developing a model for the agency’s future, post-Brexit.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor